This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI RAT CD45R
catalog :
MCA1326
quantity :
2 ml
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
HIS24 (6B6)
reactivity :
rat
application :
flow cytometry
product information
Entity Category :
Antibodies
Product Code :
MCA1326
Description :
MOUSE ANTI RAT CD45R
Specificity :
CD45R
Target Species :
Rat
Host :
Mouse
Format :
S/N
Isotypes :
IgG2b
Applications :
C*, F
Application Types :
Flow Cytometry, Immunohistology - Frozen
Clone :
HIS24 (6B6)
Quantity :
2 ml
Quantity Value :
2 ml
Quantity Type :
ml
GO Accessions :
GO:0001915, GO:0001960, GO:0005001, GO:0005887, GO:0005925, GO:0006469, GO:0006470, GO:0019887, GO:0009898, GO:0010332, GO:0019901, GO:0042100, GO:0045121, GO:0050852, GO:0050853, GO:0050857, GO:0051209, GO:0051607
GO Terms :
activation of antigen receptor-mediated signaling pathway, antiviral response, B cell receptor signalling pathway, B lymphocyte proliferation, B lymphocyte receptor signaling pathway, B lymphocyte receptor signalling pathway, B-cell proliferation, B-cell receptor signaling pathway, B-cell receptor signalling pathway, B-lymphocyte proliferation, B-lymphocyte receptor signaling pathway, B-lymphocyte receptor signalling pathway, calcium ion (Ca2+) mobilization, calcium mobilization, cytoplasmic release of sequestered calcium ion (Ca2+), cytoplasmic release of stored calcium ion (Ca2+), cytosolic release of sequestered calcium ion (Ca2+), cytosolic release of stored calcium ion (Ca2+), defence response to virus, defense response to viruses, down regulation of cytokine mediated signaling pathway, down regulation of protein kinase activity, down regulation of T cell mediated cytotoxicity, downregulation of cytokine mediated signaling pathway, down-regulation of cytokine mediated signaling pathway, downregulation of protein kinase activity, down-regulation of protein kinase activity, downregulation of T cell mediated cytotoxicity, down-regulation of T cell mediated cytotoxicity, focal contact, GEM domain, glycolipid-enriched membrane domain, GO:0008357, GO:0042114, hemi-adherens junction, inhibition of cytokine mediated signaling pathway, inhibition of protein kinase activity, inhibition of T cell mediated cytotoxicity, juxtamembrane, lipid raft, negative regulation of cytokine and chemokine mediated signaling pathway, negative regulation of cytokine mediated signaling pathway, negative regulation of cytokine mediated signalling pathway, negative regulation of T cell mediated apoptosis, negative regulation of T cell mediated cell death, negative regulation of T cell mediated cell killing, negative regulation of T cell mediated cytolysis, negative regulation of T lymphocyte mediated cytotoxicity, negative regulation of T-cell mediated apoptosis, negative regulation of T-cell mediated cell death, negative regulation of T-cell mediated cell killing, negative regulation of T-cell mediated cytolysis, negative regulation of T-cell mediated cytotoxicity, negative regulation of T-lymphocyte mediated cytotoxicity, positive regulation of antigen receptor mediated signalling pathway, protein amino acid dephosphorylation, release of sequestered calcium ion (Ca2+), release of sequestered calcium ion into cytoplasm, release of stored calcium ion (Ca2+), release of stored calcium ion (Ca2+) into cytoplasm, release of stored calcium ion (Ca2+) into cytosol, response to gamma ray, response to gamma-ray photon, stimulation of antigen receptor-mediated signaling pathway, T lymphocyte receptor signaling pathway, T lymphocyte receptor signalling pathway, T-cell receptor signaling pathway, T-cell receptor signalling pathway, TCR signaling pathway, T-lymphocyte receptor signaling pathway, T-lymphocyte receptor signalling pathway, up regulation of antigen receptor-mediated signaling pathway, up-regulation of antigen receptor-mediated signaling pathway, upregulation of antigen receptor-mediated signaling pathway
Uniprot Accessions :
P04157
Gene :
Ptprc
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=24699
EntityFormats :
S/N
UNSPSC :
41116161
Product Form :
Tissue Culture Supernatant - liquid
PrimarySecondary :
Primary
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments
